Molecular diagnosis of HIV and relevant novel technologies in mutation analysis

Biotechnology Advances

Volumn 26, Issue 5, 2008, Pages 389-397

  Xiao, L ^a,b   Zhang, J ^b,c   Yin, Y F ^d   Chen, C L ^b   Li, Kai ^a,b   Chang, A ^e   Sirois, P ^f  

^a SUZHOU UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^f UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

HIV; Molecular diagnosis; Mutation; Viral load

Indexed keywords

ANIMAL CELL CULTURE; CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; FOOD ADDITIVES; HEALTH; HEALTH RISKS; MOLECULAR BIOLOGY; MOLECULES; STANDARDIZATION; STANDARDS;

ANTI-VIRAL THERAPIES; DISEASE PROGRESSIONS; EARLY DIAGNOSIS; ELSEVIER (CO); HIV INFECTIONS; HUMAN HEALTH; MOLECULAR DIAGNOSIS; MOLECULAR IDENTIFICATION; MONITOR (CO); MUTATION ANALYSIS; NEW METHODS; REAL-TIME DETECTION; TECHNOLOGICAL ADVANCES; VIRAL LOAD;

DIAGNOSIS;

VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE TRANSMISSION; HUMAN IMMUNODEFICIENCY VIRUS; MOLECULAR ANALYSIS; MUTATION; TECHNOLOGICAL DEVELOPMENT;

BIOTECHNOLOGY; GENETIC PROCEDURES; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NUCLEOTIDE SEQUENCE; REVIEW; VIROLOGY;

BIOTECHNOLOGY; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; HIV INFECTIONS; HUMANS; MOLECULAR PROBE TECHNIQUES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 46849099216     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2008.04.007     Document Type: Review

References (43)

1. Abravaya K., Carrino J.J., Muldoon S., and Lee H.H. Detection of point mutations with a modified ligase chain reaction (Gap-LCR). Nucleic Acids Res 23 (1995) 675-682
2. Cherutich P., Inwani I., Nduati R., and Mbori-Ngacha D. Optimizing paediatric HIV care in Kenya: challenges in early infant diagnosis. Bull World Health Organ 86 (2008) 155-160
3. Collins M.L., Irvine B., Tyner D., Fine E., Zayati C., Chang C., et al. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res 25 (1997) 2979-2984
4. Daar E.S. Incorporating novel virologic tests into clinical practice. Top HIV Med 15 (2007) 126-129
5. Di Giusto D.A., and King G.C. Single base extension (SBE) with proofreading polymerases and phosphorothioate primers: improved fidelity in single-substrate assays. Nucleic Acids Res 31 (2003) e7
6. Desombere I., Van Vlierberghe H., Couvent S., Clinckspoor F., and Leroux-Roels G. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections. J Clin Microbiol 43 (2005) 2590-2597
7. Edelstein R.E., Nickerson D.A., Tobe V.O., Manns-Arcuino L.A., and Frenkel L.M. Oligonucleotide ligation assay for detecting mutations in the human immunodeficiency virus type 1 pol gene that are associated with resistance to zidovudine, didanosine, and lamivudine. J Clin Microbiol 36 (1998) 569-572
8. Fakhrai-Rad H., Zheng J., Willis T.D., Wong K., Suyenaga K., Moorhead M., et al. SNP discovery in pooled samples with mismatch repair detection. Genome Res 14 (2004) 1404-1412
9. Gottesman B.S., Grossman Z., Lorber M., Levi I., Shitrit P., Katzir M., et al. Comparative performance of the Amplicor HIV-1 Monitor Assay versus NucliSens EasyQ in HIV subtype C-infected patients. J Med Virol 78 (2006) 883-887
10. Hill C.S. Molecular diagnostic testing for infectious diseases using TMA technology. Expert Rev Mol Diagn 1 (2001) 445-455
11. Kalia V., Sarkar S., Gupta P., and Montelaro R.C. Antibody neutralization escape mediated by point mutations in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41. J Virol 79 (2005) 2097-2107
12. King G.C., Di Giusto D.A., Wlassoff W.A., Giesebrecht S., Flening E., and Tyrelle G.D. Proofreading genotyping assays and electrochemical detection of SNPs. Hum Mutat 23 (2004) 420-425
13. Liu Q., Nguyen V.Q., Li X., and Sommer S.S. Multiplex dosage pyrophosphorolysis-activated polymerization: application to the detection of heterozygous deletions. Biotechniques 40 (2006) 661-668
14. Liu Q., and Sommer S.S. Pyrophosphorolysis-activated polymerization (PAP): application to allele-specific amplification. Biotechniques 29 (2000) 1072-6, 1078 1080 passim
15. Liu Q., and Sommer S.S. PAP: detection of ultra rare mutations depends on P* oligonucleotides: "sleeping beauties" awakened by the kiss of pyrophosphorolysis. Hum Mutat 23 (2004) 426-436
16. Longo M.C., Berninger M.S., and Hartley J.L. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 93 (1990) 125-128
17. Lujan-Zilbermann J., Rodriguez C.A., and Emmanuel P.J. Pediatric HIV infection: diagnostic laboratory methods. Fetal Pediatr Pathol 25 (2006) 249-260
18. Mbanya D., Assah F., Ndembi N., and Kaptue L. Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?. Int J Infect Dis 11 (2007) 157-160
19. McClernon D.R., Vavro C., and St Clair M. Evaluation of a real-time nucleic acid sequence-based amplification assay using molecular beacons for detection of human immunodeficiency virus type 1. J Clin Microbiol 44 (2006) 2280-2282
20. Morishima C., Morgan T.R., Everhart J.E., Wright E.C., Shiffman M.L., Everson G.T., et al. HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial. Hepatology 44 (2006) 360-367
21. Murphy D.G., Cote L., Fauvel M., Rene P., and Vincelette J. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 38 (2000) 4034-4041
22. Pisani G., Cristiano K., Saldanha J., Wirz M., Bisso G.M., Mele C., et al. External quality assessment for the detection of blood-borne viruses in plasma by nucleic acid amplification technology: the first human immunodeficiency virus and hepatitis B virus studies (HIV EQA/1 and HBV EQA/1) and the fifth hepatitis C virus study (HCV EQA/5). Vox Sang 87 (2004) 91-95
23. Refseq: NC_001802, and NC_001722.
24. Report on the global AIDS epidemic 2007. http://data.unaids.org/pub/EPISlides/2007/071118_ epi_regional%20factsheet_en.pdf.
25. Robertson D.L., Anderson J.P., Bradac J.A., Carr J.K., Foley B., Funkhouser R.K., et al. HIV-1 nomenclature proposal. Science 288 (2000) 55-56
26. Sahni A.K., Gupta R.M., Jena J., and Nair M.N. Early detection of HIV-1 in infants by PCR. Indian J Pathol Microbiol 48 (2005) 49-52
27. Selvarajah S., Puffer B., Pantophlet R., Law M., Doms R.W., and Burton D.R. Comparing antigenicity and immunogenicity of engineered gp120. J Virol 79 (2005) 12148-12163
28. Stevens W., Horsfield P., and Scott L.E. Evaluation of the performance of the automated NucliSENS easyMAG and EasyQ systems versus the Roche AmpliPrep-AMPLICOR combination for high-throughput monitoring of human immunodeficiency virus load. J Clin Microbiol 45 (2007) 1244-1249
29. Swanson P., de Mendoza C., Joshi Y., Golden A., Hodinka R.L., Soriano V., et al. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J Clin Microbiol 43 (2005) 3860-3868
30. Torti C., Lapadula G., Maggiolo F., Casari S., Suter F., Minoli L., et al. Predictors of AIDS-defining events among advanced naïve patients after HAART. HIV Clin Trials 8 (2007) 112-120
31. Tournoud M., and Ecochard R. Age at which HIV infection can be detected in infants: place of the Yakovlev model. J Acquir Immune Defic Syndr 42 (2006) 362-367
32. Villahermosa M.L., Beck I., Perez-Alvarez L., Contreras G., Frenkel L.M., Osmanov S., et al. Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay. J Hum Virol 4 (2001) 238-248
33. Wallis C.L., Mahomed I., Morris L., Chidarikire T., Stevens G., Rekhviashvili N., et al. Evaluation of an oligonucleotide ligation assay for detection of mutations in HIV-1 subtype C individuals who have high level resistance to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors. J Virol Methods 125 (2005) 99-109
34. Xiao L, Zhang J, Li K. Nucleic acid identification through the coupling of primer extension and truncated primer ligation reactions. 2007, Chinese patent application #200710057414.8
35. Zetola N.M., Mintie A., Liska S., Wong E., Williams J.D., Busch M.P., et al. Performance of a transcription-mediated-amplification HIV-1 RNA assay in pooled specimens. J Clin Virol 40 (2007) 68-70
36. Zhang J., and Li K. Single-base discrimination mediated by proofreading 3′ phosphorothioate-modified primers. Mol Biotechnol 25 (2003) 223-228
37. Zhang J., and Li K. On-off regulation of 3′ exonuclease excision to DNA polymerization by Exo+ polymerase. J Biochem Mol. Biol 36 (2003) 525-528
38. Zhang J., Li K., Liao D., Pardinas J.R., Chen L., and Zhang X. Different applications of polymerases with and without proofreading activity in single-nucleotide polymorphism analysis. Lab Invest 83 (2003) 1147-1154
39. Zhang J., and Li K. New performance from an old member: SNP assay and de novo sequencing mediated by exo+ DNA polymerases. J Biochem Mol Biol 37 (2004) 269-274
40. Zhang J., Li K., Pardinas J.R., Liao D.F., Li H.J., and Zhang X. SNP discrimination through proofreading and OFF-switch of exo+ polymerase. Mol. Biotechnol 27 (2004) 75-80
41. Zhang J., Li K., Pardinas J.R., Sommer S.S., and Yao K.T. Proofreading genotyping assays mediated by high fidelity exo+ DNA polymerases. Trends Biotechnol 23 (2005) 92-96
42. Zhang J., Zhou C., Chen L., Pardinas J.R., Liu T., and Li K. Detection of known mutations with DNA polymerases: its pharmacogenetic applications. Current Pharmacogenomics 4 (2006) 121-131
43. Zhang J., Wu Y.O., Xiao L., Li K., Chen L.L., and Sioris P. Therapeutic potential of RNA interference against cellular targets of HIV infection. Mol Biotechnol 37 (2007) 225-236